Market Tracker

02/27 6:02pm ET

Theravance Inc (NASDAQ:THRX)

18.06
Delayed Data
As of Feb 27
 -0.03 / -0.17%
Today’s Change
10.58
Today|||52-Week Range
31.80
+27.63%
Year-to-Date

Today’s Trading

Previous close18.09
Today’s open18.11
Day’s range17.90 - 18.27
Volume754,396
Average volume (3 months)981,626
Market cap$2.1B
Dividend yield5.54%
Data as of 3:59pm ET, 02/27/2015

Growth & Valuation

Earnings growth (last year)+10.18%
Earnings growth (this year)+91.00%
Earnings growth (next 5 years)-167.64%
Revenue growth (last year)+77.24%
P/E ratioNM
Price/Sales188.03
Price/Book--

Competitors

 Today’s
change
Today’s
% change
INSYINSYS Therapeutics I...-0.65-1.07%
ASPXAuspex Pharmaceutica...-3.07-4.37%
IRWDIronwood Pharmaceuti...-0.58-3.62%
LCILannett Company Inc-2.77-4.25%
Data as of 4:02pm ET, 02/27/2015

Financials

Next reporting dateApril 23, 2015
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$8.4M
Annual profit (last year)-$168.5M
Net profit margin-871.93%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Michael W. Aguiar
Senior Vice President-
Operations
Frank C. Pasqualone
Corporate headquarters
South San Francisco, California

Forecasts